May 19, 2022

go health

1st long-acting injection to prevent HIV has been approved by the FDA

The world’s first injectable medication to reduce the risk of acquiring HIV has been approved by the Food and Drug Administration (FDA), the agency announced Monday (Dec. 20).

The injectable drug — called Apretude or its generic name, “cabotegravir extended-release injectable suspension” — provides an alternative to daily pills for HIV prevention, such as Truvada and Descovy. These pills are up to 99% effective at preventing the sexual transmission of HIV, but must be taken every day to be that effective, according to the Centers for Disease Control and Prevention (CDC).